| |
| |
|
| Insider
Information: |
Monia Brett P |
| Relationship: |
Director |
| City: |
Carlsbad |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
180,289 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,788,557 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
180,289 |
|
|
| Total
Value |
$6,788,557 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
9
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
7
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -99.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ionis Pharmaceuticals Inc |
IONS |
CEO Level 15, Director |
2024-02-29 |
174,289 |
2012-01-01 |
0 |
Premium* |
|
|
Cognition Therapeutics Inc |
CGTX |
Director |
2023-06-09 |
6,000 |
2023-06-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
116 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2013-06-11 |
4 |
AS |
$23.76 |
$222,750 |
D/D |
(9,375) |
5,695 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2019-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,006 |
25,847 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
VP, Antisense Drug Discovery |
• – – |
2012-09-06 |
4 |
AS |
$15.25 |
$183,473 |
D/D |
(12,031) |
5,384 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
VP, Antisense Drug Discovery |
• – – |
2012-09-06 |
4 |
OE |
$5.25 |
$63,163 |
D/D |
12,031 |
17,415 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2021-01-15 |
4 |
D |
$61.28 |
$914,727 |
D/D |
(14,927) |
48,775 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2022-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
16,198 |
96,428 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2018-08-27 |
4 |
AS |
$54.00 |
$890,622 |
D/D |
(16,493) |
15,841 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2018-08-27 |
4 |
OE |
$7.21 |
$119,274 |
D/D |
16,493 |
23,341 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2013-04-22 |
4 |
AS |
$21.26 |
$361,420 |
D/D |
(17,000) |
5,695 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2013-04-22 |
4 |
OE |
$11.12 |
$189,040 |
D/D |
17,000 |
22,695 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2023-12-21 |
4 |
OE |
$47.34 |
$828,450 |
D/D |
17,500 |
135,611 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2023-12-21 |
4 |
S |
$49.29 |
$862,577 |
D/D |
(17,500) |
118,111 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2013-03-05 |
4 |
AS |
$16.86 |
$307,599 |
D/D |
(18,240) |
5,695 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2013-03-05 |
4 |
OE |
$6.81 |
$124,214 |
D/D |
18,240 |
23,935 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2013-09-20 |
4 |
AS |
$35.89 |
$656,105 |
D/D |
(18,281) |
769 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2013-09-20 |
4 |
OE |
$11.27 |
$206,027 |
D/D |
18,281 |
19,050 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2023-07-07 |
4 |
AS |
$42.25 |
$787,953 |
D/D |
(18,650) |
121,724 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2022-01-18 |
4 |
D |
$30.12 |
$593,786 |
D/D |
(19,714) |
80,230 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2020-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
19,921 |
36,206 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2020-12-02 |
4 |
AS |
$51.32 |
$1,085,931 |
D/D |
(21,160) |
28,879 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2020-12-02 |
4 |
OE |
$39.87 |
$843,649 |
D/D |
21,160 |
50,039 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2024-02-02 |
4 |
S |
$49.37 |
$1,160,303 |
D/D |
(23,501) |
174,138 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2020-12-04 |
4 |
AS |
$51.04 |
$1,216,794 |
D/D |
(23,840) |
28,879 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2020-12-04 |
4 |
OE |
$39.87 |
$950,501 |
D/D |
23,840 |
52,719 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2023-12-14 |
4 |
OE |
$47.34 |
$1,136,160 |
D/D |
24,000 |
127,251 |
0 |
- |
|
116 Records found
|
|
Page 4 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
